Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 520
interventional 425
Observational 92
Registry 3

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 230
Device 55
Drug|placebo 50
Procedure 23
Device|Procedure 18
Drug|Other 12
Drug|Procedure 8
Other 7
Device|Drug 6
Dietary Supplement|placebo 4
Combination Product|Drug 2
Dietary Supplement 2
Drug|Other|placebo 2
Behavioral 1
Biological 1
Biological|Other 1
Biological|Procedure 1
Device|placebo 1
Diagnostic Test 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 170
NA 67
China 14
Canada 13
Japan 13
Austria 10
France 10
Germany 9
Brazil 5
Greece 5
Italy 5
Korea, Republic of 5
Poland 5
Switzerland 4
United Kingdom 4
Armenia 3
Egypt 3
Finland 3
Israel 3
Spain 3
United States|Canada 3
Australia 2
Belgium 2
Colombia|India|Panama 2
Colombia|Mexico 2
Germany|Italy|Netherlands|Spain 2
Malaysia 2
Argentina 1
Armenia|Austria|France|Germany|Greece|Italy|Poland|Spain|United Kingdom 1
Armenia|Austria|France|Germany|Italy|Spain 1
Australia|Belgium|Denmark|France|Germany|Greece|Ireland|Italy|Netherlands|Spain|Sweden|United Kingdom 1
Australia|Czechia|France|Greece|Pakistan|Portugal|Thailand|United Kingdom 1
Austria|Belgium|Czechia|France|Germany|Hungary|Italy|Latvia|Poland|Spain|United Kingdom 1
Austria|Belgium|Germany|Italy|Poland|Spain|Switzerland|United Kingdom|Venezuela 1
Austria|Germany|Mexico 1
Austria|Germany|Netherlands|Spain|Turkey 1
Bangladesh 1
Belgium|Bulgaria|France|Germany|Switzerland 1
Belgium|Israel|Italy|Portugal 1
Canada|Slovenia 1
Denmark|Finland|Norway|Sweden 1
Dominican Republic 1
Estonia 1
Estonia|Germany|Spain 1
Finland|Germany 1
Finland|Sweden 1
France|Germany|Greece|Italy|Sweden 1
France|Germany|Spain 1
France|Netherlands|Spain|Switzerland 1
Germany|Panama|Poland|Spain 1
Germany|Spain|Switzerland 1
Germany|Switzerland 1
Greece|Italy 1
Hungary 1
India|Panama 1
Iran, Islamic Republic of 1
Ireland 1
Israel|Italy|United Kingdom 1
Latvia 1
Mexico 1
Netherlands 1
Panama 1
Portugal|Spain 1
Singapore 1
South Africa 1
Sweden 1
United States|Argentina|Austria|Belgium|Brazil|Canada|Colombia|Czechia|Denmark|Egypt|France|Germany|Hong Kong|Israel|Italy|Korea, Republic of|New Zealand|Peru|Philippines|Poland|Russian Federation|Singapore|South Africa|Spain|Turkey|United Kingdom 1
United States|Argentina|Canada|Colombia|Czechia|Egypt|Germany|Italy|Korea, Republic of|Malaysia|New Zealand|Singapore|South Africa|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Denmark|Hong Kong|Hungary|Israel|Peru|Philippines|Poland|Spain|Taiwan 1
United States|Australia|Belgium|Brazil|Canada|Germany|Israel|Philippines|Singapore|Spain 1
United States|Australia|Canada|Denmark|Estonia|Germany|Israel|New Zealand|Philippines|Poland|Russian Federation|United Kingdom 1
United States|Belgium|Denmark|France|Italy|Poland|Russian Federation|Singapore|Spain|Thailand 1
United States|Brazil|Canada|Israel|Venezuela 1
United States|Bulgaria|Czech Republic|Hungary 1
United States|Bulgaria|Czechia|Denmark|France|Germany|Hungary|Ireland|Italy|Poland|South Africa|Sweden|United Kingdom 1
United States|Canada|Germany|Italy|Mexico|Philippines|Poland|Spain|United Kingdom 1
United States|Canada|Israel|Spain 1
United States|China|India|Mexico 1
United States|Estonia|Germany|Spain 1
United States|France|Italy|Netherlands|Spain|United Kingdom 1
United States|Israel 1
United States|Japan 1
United States|Singapore 1

Sites per Study

Site_count Study_Count
1 286
2 21
3 10
4 6
5 10
6 6
7 4
8 7
9 6
10 9
11 4
12 5
13 4
14 5
15 1
16 1
17 3
18 1
19 1
21 4
22 5
23 1
25 3
27 1
29 1
31 2
37 1
38 1
40 1
48 1
54 1
55 1
57 1
58 1
64 1
67 1
74 1
98 1
102 1
106 1
113 2
134 1
176 1

Phase

Phase Study_Count
N/A 104
Phase 3 103
Phase 2 94
Phase 4 85
Phase 1 22
Phase 1/Phase 2 12
Phase 2/Phase 3 4
Early Phase 1 1

Number of Arms

Number_of_Arms Count_of_Studies
1 90
2 181
3 57
4 26
5 9
6 12
8 1
12 1
14 1
NA 47

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 10 1.0000 2.00000 48.00 5.0000 60.0 20.0 15.0000
1st Qu. 10 31.5000 13.25000 61.00 56.2500 135.0 155.5 40.0000
Median 10 53.0000 23.50000 104.50 88.5000 180.5 366.0 100.0000
Mean 10 147.8932 33.59091 105.25 114.8444 168.5 406.8 155.9762
3rd Qu. 10 118.0000 53.00000 144.75 154.5000 214.0 586.0 191.2500
Max. 10 1200.0000 91.00000 191.00 656.0000 253.0 1184.0 1137.0000

Trial Group Type

group_type Group_Count
Experimental 497
Active Comparator 262
Placebo Comparator 58
Other 48
NA 47
Sham Comparator 7
No Intervention 6

Intervention Model

intervention_model Study_Count
Parallel Assignment 277
Single Group Assignment 109
Crossover Assignment 33
NA 4
Sequential Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 380
Diagnostic 15
Basic Science 9
Other 9
NA 7
Prevention 2
Device Feasibility 1
Health Services Research 1
Supportive Care 1

Observational Studies

Studies by Country

Country Study_Count
United States 29
Belgium 7
Germany 6
Austria 4
Canada 4
China 4
NA 4
Spain 4
United Kingdom 4
Korea, Republic of 3
Switzerland 3
Egypt 2
Italy 2
Austria|Bulgaria|Germany|Italy|Poland|Spain 1
Belgium|France|Germany|Hungary|Spain 1
France|Italy|Netherlands|United Kingdom 1
Germany|Netherlands 1
Greece 1
India 1
Iran, Islamic Republic of 1
Lithuania 1
Mexico 1
Netherlands 1
Singapore 1
Slovakia 1
Sweden 1
Taiwan 1
Turkey 1
United States|France|Italy|Spain|United Kingdom 1

Sites per Study

Site_count Study_Count
1 76
2 5
3 2
4 2
9 1
14 1
21 2
24 1
26 1
39 1

Enrollment Metrics

Measure Observational
Min 15.0000
1st Qu 62.0000
Median 132.0000
Mean 632.0549
3rd Qu 438.0000
Max 10337.0000

Observation Model

observational_model Study_Count
Cohort 45
Case-Only 17
Case-Control 11
NA 11
Case Control 5
Case-Crossover 2
Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 67
Retrospective 9
Cross-Sectional 7
NA 6
Other 2
Cross-Sectional, Prospective 1

Registries

Studies by Country

Country Study_Count
United States 2
Switzerland 1

Sites per Study

Site_count Study_Count
1 2
18 1

Enrollment Metrics

Measure Registries
Min 191.00
1st Qu 1394.00
Median 2597.00
Mean 10929.33
3rd Qu 16298.50
Max 30000.00

Registry Model

observational_model Study_Count
Cohort 3

Time Perspective

time_perspective Study_Count
Prospective 2
Other 1

Follow-up

target_duration Study_Count
10 Years 1
12 Months 1
36 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03365778 Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment https://ClinicalTrials.gov/show/NCT03365778 Completed Wills Eye 2018-12-01
NCT04460365 European Nutrition in Glaucoma Management Trial https://ClinicalTrials.gov/show/NCT04460365 Active, not recruiting Centre for Eye Research Ireland 2020-08-31
NCT02061683 A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension https://ClinicalTrials.gov/show/NCT02061683 Completed Allergan 2011-06-24
NCT03750201 A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty https://ClinicalTrials.gov/show/NCT03750201 Recruiting Belkin Laser Ltd. 2022-04-30
NCT03395535 Laser-1st vs Drops-1st for Glaucoma and Ocular Hypertension https://ClinicalTrials.gov/show/NCT03395535 Completed Moorfields Eye Hospital NHS Foundation Trust 2017-12-25
NCT03374553 MINIject 636 in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications https://ClinicalTrials.gov/show/NCT03374553 Active, not recruiting iSTAR Medical 2019-01-17
NCT03657797 Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT03657797 Completed Nicox Ophthalmics, Inc. 2019-08-23
NCT03822559 A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT03822559 Recruiting Santen Pharmaceutical Co., Ltd. 2022-03-31
NCT03331770 Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost https://ClinicalTrials.gov/show/NCT03331770 Completed Laboratorios Poen 2017-10-06
NCT03323164 Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study https://ClinicalTrials.gov/show/NCT03323164 Active, not recruiting Wills Eye 2018-12-31
NCT03310580 Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT03310580 Completed Aerie Pharmaceuticals 2018-10-25
NCT03293992 A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT03293992 Completed Hoffmann-La Roche 2017-12-15
NCT03292796 RCT to Investigate if Prostaglandin Analogue Drops Increase the Risk of Cystoid Macular Oedema After Cataract Surgery. https://ClinicalTrials.gov/show/NCT03292796 Active, not recruiting Norfolk and Norwich University Hospitals NHS Foundation Trust 2019-12-31
NCT03284853 Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT03284853 Active, not recruiting Aerie Pharmaceuticals 2020-12-31
NCT03273907 Post Approval Study of the CyPass System https://ClinicalTrials.gov/show/NCT03273907 Active, not recruiting Alcon Research 2021-10-31
NCT03257813 Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK) https://ClinicalTrials.gov/show/NCT03257813 Completed Laboratorios Sophia S.A de C.V. 2017-03-01
NCT03255798 A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra https://ClinicalTrials.gov/show/NCT03255798 Recruiting Glaukos Corporation 2021-12-31
NCT03233308 Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) https://ClinicalTrials.gov/show/NCT03233308 Completed Aerie Pharmaceuticals 2018-04-19
NCT03216902 A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study https://ClinicalTrials.gov/show/NCT03216902 Completed Santen Inc. 2018-02-27
NCT03204487 A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness https://ClinicalTrials.gov/show/NCT03204487 Completed Ordination Dr. Hommer 2017-04-25
NCT03201354 Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery https://ClinicalTrials.gov/show/NCT03201354 Completed Institut Catala de Retina 2015-06-30
NCT03193736 MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications https://ClinicalTrials.gov/show/NCT03193736 Completed iSTAR Medical 2018-04-16
NCT03193333 PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM) https://ClinicalTrials.gov/show/NCT03193333 Recruiting Laboratorios Sophia S.A de C.V. 2019-10-31
NCT03187418 Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma https://ClinicalTrials.gov/show/NCT03187418 Active, not recruiting Centre hospitalier de l’Université de Montréal (CHUM) 2019-02-28
NCT03267849 Lamina Cribrosa Depth Change With Change in Eye Pressure https://ClinicalTrials.gov/show/NCT03267849 Recruiting Johns Hopkins University 2020-07-01
NCT03131167 Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT03131167 Completed Shire 2018-05-30
NCT03106181 A Comparison of Cataract Surgery Alone and Cataract Surgery With iStent https://ClinicalTrials.gov/show/NCT03106181 Recruiting Center for Eye Research Australia 2020-03-31
NCT03104621 Efficacy and Tolerability of Preservative-free 0.0015% Tafluprost in Glaucoma Patients https://ClinicalTrials.gov/show/NCT03104621 Completed Gangnam Severance Hospital 2014-09-30
NCT03065036 Safety and Efficacy Study of the Hydrus Aqueous Implant in Subjects With POAG https://ClinicalTrials.gov/show/NCT03065036 Completed Ivantis, Inc. 2013-11-30
NCT02981446 A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT https://ClinicalTrials.gov/show/NCT02981446 Completed Santen Pharmaceutical Co., Ltd. 2019-01-31
NCT02959593 The Effects of Visior on Ocular Hemodynamics https://ClinicalTrials.gov/show/NCT02959593 Completed Visior Technologies Ltd. 2017-06-30
NCT02874846 Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic Solution https://ClinicalTrials.gov/show/NCT02874846 Completed Aerie Pharmaceuticals 2016-09-30
NCT02863705 Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG) https://ClinicalTrials.gov/show/NCT02863705 Completed Allergan 2018-07-25
NCT02858284 Evaluation of Safety and Efficacy of TUG (Therapeutic Ultrasound for Glaucoma) in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02858284 Completed EyeSonix 2018-08-22
NCT02829996 Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG https://ClinicalTrials.gov/show/NCT02829996 Completed Inotek Pharmaceuticals Corporation 2017-05-24
NCT02822742 A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study https://ClinicalTrials.gov/show/NCT02822742 Completed Santen Pharmaceutical Co., Ltd. 2017-04-28
NCT02822729 A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study https://ClinicalTrials.gov/show/NCT02822729 Completed Santen Pharmaceutical Co., Ltd. 2017-11-09
NCT02805257 Ahmed Glaucoma Valve Surgery With Mitomycin-C https://ClinicalTrials.gov/show/NCT02805257 Active, not recruiting University of California, San Francisco 2020-08-31
NCT02789293 Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients https://ClinicalTrials.gov/show/NCT02789293 Active, not recruiting EyeTechCare 2017-12-31
NCT02784249 A Comparison of Two Ab Interno Procedures in the Treatment of Glaucoma in Patients Undergoing Cataract Extraction https://ClinicalTrials.gov/show/NCT02784249 Active, not recruiting New World Medical, Inc. 2017-12-31
NCT02754596 Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution https://ClinicalTrials.gov/show/NCT02754596 Active, not recruiting Glaukos Corporation 2017-09-30
NCT02754570 The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure https://ClinicalTrials.gov/show/NCT02754570 Completed University of Colorado, Denver 2017-12-31
NCT02743780 A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma https://ClinicalTrials.gov/show/NCT02743780 Completed Alcon Research 2016-09-20
NCT02742649 A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02742649 Completed ForSight Vision5, Inc. 2016-12-31
NCT02700984 A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial https://ClinicalTrials.gov/show/NCT02700984 Completed Alcon Research 2018-04-18
NCT02674854 Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02674854 Completed Aerie Pharmaceuticals 2017-03-31
NCT02638181 The Expression of Matrix Metalloproteinase 13, Tissue Inhibitor of Metalloproteinases 3, and Calcium-sensing Receptor in Human Trabecular Meshwork https://ClinicalTrials.gov/show/NCT02638181 Completed Tianjin Medical University Eye Hospital 2015-12-31
NCT02622334 A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT). https://ClinicalTrials.gov/show/NCT02622334 Completed Hoffmann-La Roche 2016-07-28
NCT02622191 Analysis of the Eye in Patients With Primary Open-Angle Glaucoma and a Visual Field Defect in One Eye https://ClinicalTrials.gov/show/NCT02622191 Completed Wills Eye 2013-02-28
NCT02617459 Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02617459 Recruiting Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. 2020-12-31
NCT02636946 A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02636946 Active, not recruiting Allergan 2021-02-28
NCT02507687 Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02507687 Recruiting Allergan 2021-10-31
NCT02571712 Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02571712 Completed Allergan 2018-06-21
NCT02565173 Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT02565173 Completed Inotek Pharmaceuticals Corporation 2016-11-30
NCT02558400 Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02558400 Completed Aerie Pharmaceuticals 2017-05-17
NCT02558374 Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02558374 Completed Aerie Pharmaceuticals 2016-12-31
NCT02544646 Changes in Ocular Rigidity After Trabeculectomy in Patients With POAG https://ClinicalTrials.gov/show/NCT02544646 Completed Medical University of Vienna 2017-06-08
NCT02537015 An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert https://ClinicalTrials.gov/show/NCT02537015 Completed ForSight Vision5, Inc. 2016-08-11
NCT02531152 28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02531152 Completed Sanofi 2016-04-30
NCT02512042 Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes https://ClinicalTrials.gov/show/NCT02512042 Completed Actavis Inc. 2016-04-30
NCT02466399 POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT02466399 Completed Peregrine Ophthalmic 2016-04-30
NCT02448875 Clinical Evaluation of Visco-Assisted CyPass® Micro-Stent Implantation in Patients With Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT02448875 Completed Alcon Research 2017-06-22
NCT02434692 Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG) https://ClinicalTrials.gov/show/NCT02434692 Completed Implandata Ophthalmic Products GmbH 2017-04-11
NCT02434250 Selective Laser Trabeculoplasty After Failed Phacoemulsification With Eximer Laser Trabeculectomy https://ClinicalTrials.gov/show/NCT02434250 Completed University of Zurich 2016-10-31
NCT02419508 SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA) https://ClinicalTrials.gov/show/NCT02419508 Completed Alcon Research 2018-02-27
NCT02406833 Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy https://ClinicalTrials.gov/show/NCT02406833 Completed Isarna Therapeutics GmbH 2016-08-31
NCT02376114 Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT02376114 Completed Maisonneuve-Rosemont Hospital 2014-02-28
NCT02371746 Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT02371746 Completed Envisia Therapeutics 2019-02-13
NCT02358369 Dose-Ranging Study of the Bimatoprost Ocular Insert https://ClinicalTrials.gov/show/NCT02358369 Completed ForSight Vision5, Inc. 2015-08-31
NCT02339584 Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) https://ClinicalTrials.gov/show/NCT02339584 Completed Alcon Research 2016-11-01
NCT02338362 Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma https://ClinicalTrials.gov/show/NCT02338362 Completed University Health Network, Toronto 2015-02-28
NCT02330978 Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma. https://ClinicalTrials.gov/show/NCT02330978 Completed University of Sao Paulo 2016-09-30
NCT02312544 Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02312544 Completed Ocular Therapeutix, Inc. 2015-09-30
NCT02278614 Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients https://ClinicalTrials.gov/show/NCT02278614 Completed Laboratoires Thea 2015-11-30
NCT02272569 STARflo European Safety and Efficacy Study https://ClinicalTrials.gov/show/NCT02272569 Completed iSTAR Medical 2018-07-31
NCT02250651 Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02250651 Completed Allergan 2018-10-25
NCT02250612 SYL040012, Treatment for Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT02250612 Completed Sylentis, S.A. 2015-08-31
NCT02247804 Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02247804 Completed Allergan 2018-02-19
NCT02247284 Reproducibility of RNFL and ONH Measurements in OAG With Heidelberg Spectralis SD-OCT Glaucoma Module Premium Edition https://ClinicalTrials.gov/show/NCT02247284 Completed University of Zurich 2019-12-31
NCT02207621 Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension https://ClinicalTrials.gov/show/NCT02207621 Completed Aerie Pharmaceuticals 2016-03-31
NCT02207491 Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02207491 Completed Aerie Pharmaceuticals 2015-03-31
NCT04452279 Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification https://ClinicalTrials.gov/show/NCT04452279 Completed Vance Thompson Vision 2019-03-01
NCT02179008 Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02179008 Completed Santen Inc. 2015-01-31
NCT02177123 Post Market Study of the InnFocus MicroShunt https://ClinicalTrials.gov/show/NCT02177123 Completed InnFocus Inc. 2017-11-27
NCT02143843 An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product https://ClinicalTrials.gov/show/NCT02143843 Completed ForSight Vision5, Inc. 2015-12-31
NCT02140060 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02140060 Completed Alcon Research 2014-11-30
NCT02129673 A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02129673 Completed ViSci Ltd. 2017-05-31
NCT02114073 Comparison of Effect of Postoperative Cyclosporine A 2% Ophthalmic Emulsion and Betamethasone Eye Drop on Surgical Success of Trabeculectomy Procedure https://ClinicalTrials.gov/show/NCT02114073 Completed Mashhad University of Medical Sciences 2014-11-30
NCT02083289 A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG) https://ClinicalTrials.gov/show/NCT02083289 Completed Ono Pharmaceutical Co. Ltd 2014-12-31
NCT02077231 Study of Vitamin A and Carbomer in Comforting the Ocular Surface Irritations of Glaucoma Patients https://ClinicalTrials.gov/show/NCT02077231 Completed Shanghai Jinshan Hospital 2013-02-28
NCT02059278 Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02059278 Completed Nephron Pharmaceuticals Corporation 2015-01-31
NCT01318252 AL-54478 Proof of Concept Study https://ClinicalTrials.gov/show/NCT01318252 Completed Alcon Research 2011-10-31
NCT01310777 Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01310777 Completed Alcon Research 2013-01-31
NCT01309204 Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01309204 Completed Alcon Research 2013-01-31
NCT01306461 Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations https://ClinicalTrials.gov/show/NCT01306461 Completed Santen Oy 2012-04-30
NCT01298687 Divided Dose of TRAVATAN® https://ClinicalTrials.gov/show/NCT01298687 Completed Alcon Research 2011-04-30
NCT01297920 Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2% https://ClinicalTrials.gov/show/NCT01297920 Completed Alcon Research 2012-06-30
NCT01297517 Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2% https://ClinicalTrials.gov/show/NCT01297517 Completed Alcon Research 2012-03-31
NCT01292460 Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies https://ClinicalTrials.gov/show/NCT01292460 Completed Santen Oy 2012-09-30
NCT01291108 Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01291108 Completed Allergan 2011-10-31
NCT01282346 SOLX Gold Shunt for Refractory Glaucoma https://ClinicalTrials.gov/show/NCT01282346 Completed SOLX, Inc. 2015-12-31
NCT01279083 Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01279083 Completed Santen Inc. 2011-11-30
NCT02023242 Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes https://ClinicalTrials.gov/show/NCT02023242 Completed Ivantis, Inc. 2017-08-31
NCT02057575 Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure https://ClinicalTrials.gov/show/NCT02057575 Completed Aerie Pharmaceuticals 2014-06-30
NCT02020512 A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension https://ClinicalTrials.gov/show/NCT02020512 Completed Allergan 2012-12-31
NCT02017327 Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose https://ClinicalTrials.gov/show/NCT02017327 Completed Laboratoires Thea 2016-07-31
NCT02016898 The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device https://ClinicalTrials.gov/show/NCT02016898 Completed Duke University 2017-01-17
NCT02003391 Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure https://ClinicalTrials.gov/show/NCT02003391 Completed Alcon Research 2015-05-31
NCT01979913 An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More https://ClinicalTrials.gov/show/NCT01979913 Completed Ordination Dr. Hommer 2014-04-30
NCT01978600 Evaluation of Intraocular Pressure Using Simbrinzaâ„¢ in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01978600 Completed Alcon Research 2014-03-31
NCT01956942 Micropulse Laser Trabeculoplasty (MLT) Versus Selective Laser Trabeculoplasty (SLT) for Treatment of Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT01956942 Completed George Washington University 2017-07-31
NCT01937312 Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue https://ClinicalTrials.gov/show/NCT01937312 Completed Alcon Research 2014-05-31
NCT01937299 Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z® https://ClinicalTrials.gov/show/NCT01937299 Completed Alcon Research 2014-04-30
NCT01936389 A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma https://ClinicalTrials.gov/show/NCT01936389 Completed Robert Ritch, MD, LLC. 2014-10-31
NCT01930487 The Effects of an Antioxidant Formulation on Ocular Blood Flow https://ClinicalTrials.gov/show/NCT01930487 Completed ScienceBased Health 2015-07-31
NCT01917383 A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT01917383 Completed Inotek Pharmaceuticals Corporation 2014-08-31
NCT01915940 Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01915940 Completed ForSight Vision5, Inc. 2014-09-30
NCT01896180 Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost https://ClinicalTrials.gov/show/NCT01896180 Completed Alleanza Pharmaceuticals, Inc. 2014-01-31
NCT01887873 Safety of Hyaluronan Thiomer i.o. Implant During Combined Phacoemulsification - Non Penetrating Deep Sclerectomy https://ClinicalTrials.gov/show/NCT01887873 Completed Croma-Pharma GmbH 2014-04-30
NCT01887223 Transconjunctival Needling Revision Versus Medical Treatment https://ClinicalTrials.gov/show/NCT01887223 Completed University of Sao Paulo General Hospital 2011-06-30
NCT01881425 InnFocus MicroShunt Versus Trabeculectomy Study https://ClinicalTrials.gov/show/NCT01881425 Active, not recruiting InnFocus Inc. 2018-12-31
NCT01868126 Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01868126 Completed Santen Inc. 2013-08-31
NCT01849536 Corneal Biomechanics and Continuous IOP Monitoring Using Soft Contact Lenses in Glaucomatous Patients https://ClinicalTrials.gov/show/NCT01849536 Completed University Hospital, Bordeaux 2013-10-31
NCT01845038 Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT01845038 Completed Ocular Therapeutix, Inc. 2014-03-31
NCT01841450 Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery https://ClinicalTrials.gov/show/NCT01841450 Active, not recruiting Glaukos Corporation 2021-05-31
NCT01833741 A Study of LUMIGAN® RC in the Clinical Setting https://ClinicalTrials.gov/show/NCT01833741 Completed Allergan 2011-03-31
NCT01818115 Safety and Efficacy Trial to Evaluate the Hydrus(TM) Implant in Subjects Undergoing Cataract Surgery. https://ClinicalTrials.gov/show/NCT01818115 Completed Ivantis, Inc. 2015-08-31
NCT01798732 PIO Laser Sclerectomy IOP SLT Sclerectomy https://ClinicalTrials.gov/show/NCT01798732 Completed University Hospital, Grenoble 2014-11-30
NCT01789736 A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days https://ClinicalTrials.gov/show/NCT01789736 Completed Aerie Pharmaceuticals 2013-06-30
NCT01788319 Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm) https://ClinicalTrials.gov/show/NCT01788319 Completed Universitaire Ziekenhuizen Leuven 2014-12-31
NCT01767753 IOP Fluctuations in Patients With Primary Open-angle Glaucoma, Before and After Selective Laser Trabeculoplasty https://ClinicalTrials.gov/show/NCT01767753 Completed Sensimed AG 2014-07-31
NCT01749930 Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01749930 Completed Bausch & Lomb Incorporated 2015-05-31
NCT01749904 Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01749904 Completed Bausch & Lomb Incorporated 2015-06-02
NCT01739244 Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT01739244 Completed Sylentis, S.A. 2013-05-31
NCT01731002 Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure https://ClinicalTrials.gov/show/NCT01731002 Completed Aerie Pharmaceuticals 2013-05-31
NCT01711177 Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT01711177 Completed Université de Montréal 2013-03-31
NCT01707381 BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01707381 Completed Bausch & Lomb Incorporated 2013-12-31
NCT01699464 A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months https://ClinicalTrials.gov/show/NCT01699464 Completed Aerie Pharmaceuticals 2013-04-30
NCT01693315 Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT01693315 Completed Amakem, NV 2013-07-31
NCT01687426 Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01687426 Completed Eye Therapies, LLC 2012-12-31
NCT01670266 Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT01670266 Completed Ono Pharmaceutical Co. Ltd 2013-05-31
NCT01668524 ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects https://ClinicalTrials.gov/show/NCT01668524 Completed Altheos, Inc. 2012-08-31
NCT01640756 AqueSys Microfistula Implant in Refractory Glaucoma https://ClinicalTrials.gov/show/NCT01640756 Completed AqueSys, Inc. 2014-11-30
NCT01594970 A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH) https://ClinicalTrials.gov/show/NCT01594970 Completed Allergan 2013-01-31
NCT01563237 Safety and Performance of Miami InnFocus Drainage Implant (MIDI Arrow) Glaucoma Drainage Implant https://ClinicalTrials.gov/show/NCT01563237 Completed InnFocus Inc. 2016-12-31
NCT01560975 IOP Fluctuations in Patients With Sleep Apnea With or Without Primary Open Angle Glaucoma Using Positive Airway Pressure https://ClinicalTrials.gov/show/NCT01560975 Completed Sensimed AG 2012-11-30
NCT01547598 Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction https://ClinicalTrials.gov/show/NCT01547598 Completed Allergan 2013-07-31
NCT01540331 Efficacy And Safety of Pneumatic Trabeculoplasty https://ClinicalTrials.gov/show/NCT01540331 Completed University of Catanzaro 2011-06-30
NCT01539239 Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery (HORIZON) https://ClinicalTrials.gov/show/NCT01539239 Active, not recruiting Ivantis, Inc. 2017-06-30
NCT02024464 Comparing Hydrus Microstent(TM) to the iStent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery https://ClinicalTrials.gov/show/NCT02024464 Completed Ivantis, Inc. 2017-03-31
NCT01528787 Study of AR-13324 in Patients With Elevated Intraocular Pressure https://ClinicalTrials.gov/show/NCT01528787 Completed Aerie Pharmaceuticals 2012-07-31
NCT01528111 Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01528111 Completed Lexicon Pharmaceuticals 2012-06-30
NCT01510145 Efficacy of Changing to TRAVATAN® From Prior Therapy https://ClinicalTrials.gov/show/NCT01510145 Completed Alcon Research 2013-05-31
NCT01494753 Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01494753 Completed Laboratoires Thea 2008-12-31
NCT01493271 A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT01493271 Completed Hoffmann-La Roche 2012-11-30
NCT01481077 A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT01481077 Completed Mati Therapeutics Inc. 2012-09-30
NCT01481051 A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT01481051 Completed Mati Therapeutics Inc. 2012-09-30
NCT01464424 Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®) https://ClinicalTrials.gov/show/NCT01464424 Completed Alcon Research 2012-06-30
NCT01461291 Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery https://ClinicalTrials.gov/show/NCT01461291 Active, not recruiting Glaukos Corporation 2017-08-04
NCT01461278 Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery https://ClinicalTrials.gov/show/NCT01461278 Active, not recruiting Glaukos Corporation 2020-12-31
NCT01453855 Travoprost 3-Month Safety and Efficacy Study https://ClinicalTrials.gov/show/NCT01453855 Completed Alcon Research 2012-08-31
NCT01443988 Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost https://ClinicalTrials.gov/show/NCT01443988 Completed Glaukos Corporation 2017-01-31
NCT01426867 A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2% https://ClinicalTrials.gov/show/NCT01426867 Completed Alcon Research 2011-11-30
NCT01415401 Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada https://ClinicalTrials.gov/show/NCT01415401 Completed Alcon Research 2013-06-30
NCT01410188 Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01410188 Completed Kubota Vision Inc. 2012-10-31
NCT01409421 RESEARCH PROTOCOL: Glaucoma Treatment Adherence and Persistence https://ClinicalTrials.gov/show/NCT01409421 Completed University of Colorado, Denver 2013-01-31
NCT01408472 NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement https://ClinicalTrials.gov/show/NCT01408472 Completed Stanford University 2013-12-31
NCT01391078 Comparison of Sensimed Triggerfish With Goldmann Applanation Tonometry and Perkins Tonometry https://ClinicalTrials.gov/show/NCT01391078 Completed Johannes Gutenberg University Mainz 2012-01-31
NCT01390779 Efficacy of 24-hour Intraocular Pressure Fluctuation Recording With the SENSIMED Triggerfish Contact Lens Sensor https://ClinicalTrials.gov/show/NCT01390779 Completed Sensimed AG 2012-05-31
NCT01384149 EXTERNAL SLT Treatment in Patients With Uncontrolled OPEN ANGLE GLAUCOMA https://ClinicalTrials.gov/show/NCT01384149 Completed Meir Medical Center 2012-01-31
NCT01383525 Direct Application of Selective Laser Trabeculoplasty in Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT01383525 Completed Belkin Laser Ltd. 2019-08-31
NCT01379144 A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension https://ClinicalTrials.gov/show/NCT01379144 Completed Pfizer 2003-03-31
NCT01369771 The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma https://ClinicalTrials.gov/show/NCT01369771 Completed FinnMedi Oy 2012-06-30
NCT01364207 The Effects of Caffeinated Coffee on Intraocular Pressure https://ClinicalTrials.gov/show/NCT01364207 Completed Massachusetts Eye and Ear Infirmary 2011-08-31
NCT01357616 Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01357616 Completed Alcon Research 2013-01-31
NCT01343082 DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01343082 Completed Santen Pharmaceutical Co., Ltd. 2013-03-31
NCT01342094 DE-111 Against Timolol Ophthalmic Solution 0.5% https://ClinicalTrials.gov/show/NCT01342094 Completed Santen Pharmaceutical Co., Ltd. 2012-09-30
NCT01342081 DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5% https://ClinicalTrials.gov/show/NCT01342081 Completed Santen Pharmaceutical Co., Ltd. 2012-09-30
NCT01340014 Patient Preference Comparison of AZARGA Versus COSOPT https://ClinicalTrials.gov/show/NCT01340014 Completed Alcon Research 2012-10-31
NCT01330979 24-hour Efficacy of AR-12286 https://ClinicalTrials.gov/show/NCT01330979 Completed Aerie Pharmaceuticals 2012-08-31
NCT01327599 Efficacy of Changing to DUOTRAV® From Prior Therapy https://ClinicalTrials.gov/show/NCT01327599 Completed Alcon Research 2012-11-30
NCT04285580 A Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT04285580 Recruiting Allergan 2021-03-12
NCT01769521 Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG https://ClinicalTrials.gov/show/NCT01769521 Completed Sensimed AG 2013-04-30
NCT04448223 A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 https://ClinicalTrials.gov/show/NCT04448223 Recruiting Chong Kun Dang Pharmaceutical 2022-12-05
NCT04445519 Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT04445519 Recruiting Nicox Ophthalmics, Inc. 2021-12-31
NCT04430647 Phaco-UCP Versus Phaco Alone for OAG and Cataract https://ClinicalTrials.gov/show/NCT04430647 Completed Mansoura University 2019-09-01
NCT04422743 Effect of Citicoline/Homotaurine on PERG in Primary Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT04422743 Active, not recruiting IRCCS Policlinico S. Matteo 2020-09-30
NCT04405245 Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypotension or Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT04405245 Recruiting Aerpio Therapeutics 2020-12-31
NCT04360174 CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT04360174 Recruiting Ocular Therapeutix, Inc. 2020-10-31
NCT04334564 Effect of Ginkgo Biloba Capsule on Visual Function of Primary Open-angle Glaucoma With Blood Stasis Syndrome https://ClinicalTrials.gov/show/NCT04334564 Recruiting Zhongshan Ophthalmic Center, Sun Yat-sen University 2020-10-30
NCT04321122 UCP (Ultrasound Cyclo Plasty) in the Treatment of Chinese Patients With Primary Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT04321122 Recruiting Zhongshan Ophthalmic Center, Sun Yat-sen University 2020-03-12
NCT04284514 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solution https://ClinicalTrials.gov/show/NCT04284514 Completed Aerpio Therapeutics 2019-12-15
NCT04234932 Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation https://ClinicalTrials.gov/show/NCT04234932 Recruiting University of the Incarnate Word 2021-01-31
NCT04215575 Baerveldt (BGI) Valve Versus Ahmed(AGV) Valve in Management of Difficult Glaucoma Cases https://ClinicalTrials.gov/show/NCT04215575 Completed Ain Shams University 2016-12-01
NCT04214847 The Outcome of Ahmed Glaucoma Valve in Difficult Glaucoma Cases https://ClinicalTrials.gov/show/NCT04214847 Completed Ain Shams University 2014-03-12
NCT04205201 The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT04205201 Completed Chittagong Medical College 2019-09-24
NCT04202562 Efficacy and Safety of ab Interno Trabeculectomy With the Kahook Dual Blade https://ClinicalTrials.gov/show/NCT04202562 Completed Hospital San Carlos, Madrid 2017-11-29
NCT04202510 IOP and Medication Reduction in MIGS Procedures https://ClinicalTrials.gov/show/NCT04202510 Recruiting Wills Eye 2021-12-31
NCT04188015 Study of ANX007 in Participants With Primary Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT04188015 Completed Annexon, Inc. 2019-06-03
NCT04155164 Effect of Metformin on Visual Function in Patients With Glaucoma https://ClinicalTrials.gov/show/NCT04155164 Recruiting Zhongshan Ophthalmic Center, Sun Yat-sen University 2021-05-31
NCT04149899 Safety and IOP-Lowering Effects of WB007 https://ClinicalTrials.gov/show/NCT04149899 Recruiting Whitecap Biosciences, LLC 2020-06-30
NCT04133311 A Phase III Multinational Multicenter Investigator-Masked Randomised Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT04133311 Recruiting Santen SAS 2020-12-31
NCT04098861 Efficacy and Safety of Latanoprost/Timolol for Primary Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT04098861 Recruiting Universiti Kebangsaan Malaysia Medical Centre 2020-08-31
NCT04061044 A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert https://ClinicalTrials.gov/show/NCT04061044 Active, not recruiting Ocular Therapeutix, Inc. 2020-02-29
NCT04038034 Valuation of the Antioxidant and Neuroprotective Effects of CoQ10-MINIACTIVES® (COQUN® OS) in Patients Affected by Primary Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT04038034 Recruiting VISUfarma SpA 2021-08-30
NCT04024072 To Compare the Safety and Efficacy of Perrigo’s Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes https://ClinicalTrials.gov/show/NCT04024072 Active, not recruiting Perrigo Company 2020-02-26
NCT04005079 Pilocarpine After Combined Cataract/Trabectome Surgery https://ClinicalTrials.gov/show/NCT04005079 Recruiting Montefiore Medical Center 2022-07-31
NCT03996200 MINIject in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool https://ClinicalTrials.gov/show/NCT03996200 Active, not recruiting iSTAR Medical 2020-02-14
NCT03966560 Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT03966560 Completed Afyon Kocatepe University Hospital 2015-01-31
NCT03960866 Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma https://ClinicalTrials.gov/show/NCT03960866 Completed Ocuphire Pharma, Inc. 2019-09-11
NCT03931564 Cost-effectiveness of InnFocus Microshunt Implantation vs. Trabeculectomy. https://ClinicalTrials.gov/show/NCT03931564 Recruiting Maastricht University Medical Center 2022-07-31
NCT03931317 Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity https://ClinicalTrials.gov/show/NCT03931317 Recruiting University of California, San Diego 2020-12-31
NCT03921931 Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study https://ClinicalTrials.gov/show/NCT03921931 Recruiting Medical University of Vienna 2019-12-31
NCT03904381 Efficacy and Safety of XEN® Gel Stent and Post-operative Management in Patients With Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT03904381 Recruiting Wroclaw Medical University 2024-01-01
NCT03891446 Long-term Safety and Efficacy Extension Trial of Bimatoprost SR https://ClinicalTrials.gov/show/NCT03891446 Recruiting Allergan 2024-01-21
NCT03875911 Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Application of Mitomycin-C (Conventional Use) in Trabeculectomy https://ClinicalTrials.gov/show/NCT03875911 Recruiting University of California, Los Angeles 2020-12-31
NCT03868124 Clinical Study Comparing Two Models of a Travoprost Intraocular Implant https://ClinicalTrials.gov/show/NCT03868124 Recruiting Glaukos Corporation 2021-06-30
NCT03861169 Use of the OMNI® Surgical System in Combination With Cataract Extraction in Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT03861169 Recruiting Sight Sciences, Inc. 2020-08-30
NCT03858894 Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6 https://ClinicalTrials.gov/show/NCT03858894 Completed Santen Inc. 2019-06-20
NCT03850782 Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT03850782 Recruiting Allergan 2023-07-17
NCT03844945 Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan https://ClinicalTrials.gov/show/NCT03844945 Completed Aerie Pharmaceuticals 2019-09-19
NCT03808688 Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting https://ClinicalTrials.gov/show/NCT03808688 Completed Aerie Pharmaceuticals 2019-07-26
NCT03807869 Reduction of Intraocular Pressure After I-stent By-pass Implantation in Eyes With Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT03807869 Completed Medical University of Bialystok 2019-12-01
NCT03804684 visuALL Field Analyzer (vFA) Compared to Standard Automatic Perimetry https://ClinicalTrials.gov/show/NCT03804684 Recruiting Wills Eye 2020-09-30
NCT03800589 Assessment of Effectiveness Ex-Press Surgery Modification https://ClinicalTrials.gov/show/NCT03800589 Completed Military Institute of Medicine, Poland 2016-12-01
NCT03798223 Optimal Treatment Protocol for Selective Laser Trabeculoplasty https://ClinicalTrials.gov/show/NCT03798223 Enrolling by invitation Vastra Gotaland Region 2024-01-31
NCT03797469 Nutritional Supplements and Performance During Visual Field Testing (B3 Vitamin) https://ClinicalTrials.gov/show/NCT03797469 Recruiting Columbia University 2020-03-31
NCT03782051 Combined Viscocanalostomy, Phacoemulsification, OIogen Implant in Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT03782051 Completed Zagazig University 2018-01-14
NCT03736655 Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT03736655 Recruiting Ciliatech 2020-04-01
NCT03697811 DE-117 Spectrum 5 Study https://ClinicalTrials.gov/show/NCT03697811 Recruiting Santen Inc. 2020-12-31
NCT03689088 Sensing Contact Lens-based Device for 24-hour Monitoring of Intraocular Pressure https://ClinicalTrials.gov/show/NCT03689088 Completed Sensimed AG 2018-07-04
NCT03675412 Caffeine Consumption in Glaucoma Patients and Healthy Subjects https://ClinicalTrials.gov/show/NCT03675412 Recruiting Wills Eye 2020-12-30
NCT03624699 Investigation of the iStent Inject® Devices in Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT03624699 Recruiting Swiss Vision Network 2019-12-31
NCT03624361 MINIject Glaucoma Implant in European Patients https://ClinicalTrials.gov/show/NCT03624361 Active, not recruiting iSTAR Medical 2019-12-31
NCT03612817 Preservative-free Tafluprost/Timolol Fixed Combination: Morning vs Evening Dosing https://ClinicalTrials.gov/show/NCT03612817 Completed Aristotle University Of Thessaloniki 2018-04-30
NCT03611530 CoQun Study - (COQUN): a Study to Evaluate the Effects of CoQun in Patients Affected by Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT03611530 Recruiting Mario Negri Institute for Pharmacological Research 2021-02-28
NCT03604328 Safety and Tolerability of a Prostaglandin Ocular Implant for Treatment of Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT03604328 Active, not recruiting PolyActiva Pty Ltd 2020-05-31
NCT03558126 Silicone Tube for the Surgical Treatment of Glaucoma https://ClinicalTrials.gov/show/NCT03558126 Completed Wenzhou Medical University 2016-04-01
NCT03534882 Effects of Prostaglandin Analogue Washout Following Long-term Therapy in Adults With Primary Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT03534882 Completed Western University, Canada 2017-06-22
NCT03529591 Is the Reduction in IOP After Treatment of 180 Degrees Equivalent to Treatment of 360 Degrees With SLT? https://ClinicalTrials.gov/show/NCT03529591 Recruiting Western University, Canada 2020-07-30
NCT03519386 Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5% https://ClinicalTrials.gov/show/NCT03519386 Recruiting Glaukos Corporation 2021-06-30
NCT03488550 Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT03488550 Completed Annexon, Inc. 2018-08-03
NCT03483402 Micropulse Laser Trabeculoplasty as Adjunctive Treatment in Patients With Pseudoexfoliation Glaucoma https://ClinicalTrials.gov/show/NCT03483402 Completed University Hospital of Patras 2018-03-30
NCT03478293 iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications https://ClinicalTrials.gov/show/NCT03478293 Recruiting Glaukos Corporation 2021-06-30
NCT03450629 Evaluation of Safety and Efficacy of Brimonidine Tartrate Ophthalmic Suspension https://ClinicalTrials.gov/show/NCT03450629 Recruiting Sun Pharma Advanced Research Company Limited 2020-12-29
NCT03419975 A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients https://ClinicalTrials.gov/show/NCT03419975 Completed Taejoon Pharmaceutical Co., Ltd. 2017-12-28
NCT01254604 Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002) https://ClinicalTrials.gov/show/NCT01254604 Completed Merck Sharp & Dohme Corp. 2013-05-09
NCT01253902 Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01253902 Completed Allergan 2011-10-31
NCT01252888 Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStents https://ClinicalTrials.gov/show/NCT01252888 Completed Glaukos Corporation 2016-07-31
NCT01252862 Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents https://ClinicalTrials.gov/show/NCT01252862 Completed Glaukos Corporation 2016-07-31
NCT01243567 Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated https://ClinicalTrials.gov/show/NCT01243567 Completed Allergan 2012-02-14
NCT01241240 Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01241240 Completed Allergan 2013-09-30
NCT01229982 A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT01229982 Completed Mati Therapeutics Inc. 2011-08-31
NCT01217606 Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01217606 Completed Allergan 2014-09-30
NCT01215786 Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT01215786 Completed Allergan 2010-12-31
NCT01212861 Surgical Treatment of Refractory Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT01212861 Completed iScience Interventional Corporation 2012-05-31
NCT01168414 A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01168414 Completed Ministry of Health, Malaysia 2011-01-31
NCT01166659 Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy https://ClinicalTrials.gov/show/NCT01166659 Completed Alcon Research 2013-05-31
NCT01162603 Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP) https://ClinicalTrials.gov/show/NCT01162603 Completed Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 2012-04-30
NCT01157364 Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension https://ClinicalTrials.gov/show/NCT01157364 Completed Allergan 2016-07-27
NCT01123785 A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT01123785 Completed Inotek Pharmaceuticals Corporation 2011-12-31
NCT01114893 Travoprost Five Day Posology Study https://ClinicalTrials.gov/show/NCT01114893 Completed Alcon Research 2010-05-31
NCT01110499 Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01110499 Completed Allergan 2011-05-31
NCT01085357 Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery https://ClinicalTrials.gov/show/NCT01085357 Completed Alcon Research 2015-03-31
NCT01068964 Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01068964 Completed Allergan 2010-09-01
NCT01062971 Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide https://ClinicalTrials.gov/show/NCT01062971 Completed Laboratorios Sophia S.A de C.V. 2007-08-31
NCT01058278 Impact Post-operative Treatment on Intraocular Pressure Post-SLT on Patients With Primary Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT01058278 Completed CHU de Quebec-Universite Laval 2012-06-30
NCT01055366 ELAZOP Switching Study in Korea https://ClinicalTrials.gov/show/NCT01055366 Completed Alcon Research 2011-12-31
NCT01053416 Pigment Dispersion Syndrome: Natural History and Possible Protective Effect of a YAG Laser Iridotomy https://ClinicalTrials.gov/show/NCT01053416 Completed University of Parma 2003-04-30
NCT01037036 A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG https://ClinicalTrials.gov/show/NCT01037036 Completed Mati Therapeutics Inc. 2010-04-30
NCT01026831 Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED) https://ClinicalTrials.gov/show/NCT01026831 Completed Merck Sharp & Dohme Corp. 2010-09-17
NCT01001195 Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution https://ClinicalTrials.gov/show/NCT01001195 Completed Allergan 2010-04-30
NCT00991822 A Comparison of the Effect of Dorzolamide and Timolol on Optic Disk Blood Flow in Patients With Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT00991822 Completed Medical University of Vienna 2001-12-31
NCT00966940 Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00966940 Completed Alcon Research 2010-03-31
NCT00947661 Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00947661 Completed Sun Pharma Advanced Research Company Limited 2012-05-31
NCT00945958 Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00945958 Completed Sun Pharma Advanced Research Company Limited 2012-06-30
NCT00941525 Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure https://ClinicalTrials.gov/show/NCT00941525 Completed Aristotle University Of Thessaloniki 2014-07-31
NCT00934089 A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 https://ClinicalTrials.gov/show/NCT00934089 Completed Pfizer 2010-06-30
NCT00928590 Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00928590 Completed Alcon Research 2010-11-30
NCT00918346 Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation https://ClinicalTrials.gov/show/NCT00918346 Completed Santen Oy 2006-03-31
NCT00913029 Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG) https://ClinicalTrials.gov/show/NCT00913029 Completed Glaukos Corporation 2012-09-30
NCT00911924 A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT00911924 Completed Glaukos Corporation 2013-09-30
NCT03870230 Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects https://ClinicalTrials.gov/show/NCT03870230 Recruiting Medical University of Vienna 2020-12-31
NCT00892762 Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health https://ClinicalTrials.gov/show/NCT00892762 Completed Alcon Research 2011-05-31
NCT00887029 A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT00887029 Completed Ophthalmic Consultants Centres, Canada 2009-11-30
NCT00878917 Equivalence Study of Dorzolamide 2% Eye Drops Solution https://ClinicalTrials.gov/show/NCT00878917 Completed Alfred E. Tiefenbacher (GmbH & Co. KG) 2010-02-28
NCT00872651 Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00872651 Completed Alcon Research 2011-11-30
NCT00868894 Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00868894 Completed Santen Inc. 2010-05-31
NCT00856622 A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients https://ClinicalTrials.gov/show/NCT00856622 Completed Pfizer 1999-06-30
NCT00848536 Efficacy Study of Travoprost APS Versus TRAVATAN https://ClinicalTrials.gov/show/NCT00848536 Completed Alcon Research 2010-01-31
NCT00847158 A Clinical Trial of Phacoemulsification Versus Phacoemulsification & the iStent Implantation in POAG Patients https://ClinicalTrials.gov/show/NCT00847158 Completed University of Turin, Italy 2008-03-31
NCT00845299 Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT00845299 Completed Mati Therapeutics Inc. 2009-12-31
NCT00838721 Evaluation of Pascal Laser Trabeculoplaty https://ClinicalTrials.gov/show/NCT00838721 Completed Santa Clara Valley Health & Hospital System 2010-03-31
NCT02136940 Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02136940 Completed Amakem, NV 2014-11-30
NCT02036541 AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma https://ClinicalTrials.gov/show/NCT02036541 Completed AqueSys, Inc. 2016-02-29
NCT01087671 Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops https://ClinicalTrials.gov/show/NCT01087671 Completed Santen Oy 2010-10-31
NCT01016691 Safety and Efficacy of a Drug Delivery System in Glaucoma https://ClinicalTrials.gov/show/NCT01016691 Completed Vistakon Pharmaceuticals 2010-02-28
NCT00834223 A Prospective, Multicenter, Open-label, Safety and Preliminary Efficacy Study of the Surgical Implantation of OPKO’s Glaucoma Drainage Device (AquashuntTM) in Patients With Refractory Chronic Forms of Open Angle Glaucoma (OAG) https://ClinicalTrials.gov/show/NCT00834223 Completed OPKO Health, Inc. 2009-09-30
NCT00828906 DuoTrav® Eye Drops As Replacement Therapy Program https://ClinicalTrials.gov/show/NCT00828906 Completed Alcon Research 2009-11-30
NCT00824824 Effect of Cosopt Versus Combigan on Retinal Vascular Autoregulation in Primary Open Angle Glaucoma (POAG) https://ClinicalTrials.gov/show/NCT00824824 Completed Massachusetts Eye and Ear Infirmary 2012-08-31
NCT00824720 Safety and Efficacy of a Glaucoma Drug Delivery System https://ClinicalTrials.gov/show/NCT00824720 Completed Vistakon Pharmaceuticals 2009-04-30
NCT00822081 Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00822081 Completed Bp Consulting, Inc 2006-04-30
NCT00822055 Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00822055 Completed Allergan 2006-11-30
NCT03480711 Modified Trabeculectomy With an ESST Versus Conventional SST for Management of Primary Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT03480711 Completed Cairo University 2019-02-28
NCT02014142 A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT02014142 Completed Mati Therapeutics Inc. 2016-12-31
NCT02003534 A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension https://ClinicalTrials.gov/show/NCT02003534 Completed Allergan 2013-02-28
NCT00820300 A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT00820300 Completed Mati Therapeutics Inc. 2009-12-31
NCT02006693 Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants https://ClinicalTrials.gov/show/NCT02006693 Completed AqueSys, Inc. 2016-02-09
NCT01943721 A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01943721 Completed ForSight Vision5, Inc. 2014-06-30
NCT01493427 Efficacy of Changing to TRAVATAN® From Prior Therapy https://ClinicalTrials.gov/show/NCT01493427 Completed Alcon Research 2013-02-28
NCT00804648 Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00804648 Completed Vistakon Pharmaceuticals 2008-12-31
NCT00804102 Transcorneal Electrical Stimulation Therapy for Retinal Disease https://ClinicalTrials.gov/show/NCT00804102 Completed Okuvision GmbH 2011-04-30
NCT00803803 Dose, Effects and Characteristics of Pilocarpine https://ClinicalTrials.gov/show/NCT00803803 Completed Wills Eye 1979-08-31
NCT02914509 OTX-16-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-TP in Subjects With Open-Angle Glaucoma and Ocular Hypertension https://ClinicalTrials.gov/show/NCT02914509 Completed Ocular Therapeutix, Inc. 2019-03-30
NCT04352660 Subconjunctival Versus Direct Mitomycin C in Trabeculectomy https://ClinicalTrials.gov/show/NCT04352660 Completed University of California, San Diego 2019-04-14
NCT02623738 A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study- https://ClinicalTrials.gov/show/NCT02623738 Completed Santen Pharmaceutical Co., Ltd. 2017-02-10
NCT02325518 Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution https://ClinicalTrials.gov/show/NCT02325518 Completed Alcon Research 2015-12-31
NCT02327312 Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty https://ClinicalTrials.gov/show/NCT02327312 Recruiting Glaukos Corporation 2021-02-28
NCT03756662 Performance and Safety of the ARGOS-SC01 Suprachoroidal Pressure Sensor in Patients With Glaucoma Undergoing Non-penetrating Glaucoma Surgery https://ClinicalTrials.gov/show/NCT03756662 Recruiting Implandata Ophthalmic Products GmbH 2020-03-01
NCT03651336 Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG) https://ClinicalTrials.gov/show/NCT03651336 Recruiting Implandata Ophthalmic Products GmbH 2021-10-31
NCT03452033 H-1337 Ophthalmic Solution Phase 1/2 https://ClinicalTrials.gov/show/NCT03452033 Completed Allysta Pharmaceutical 2018-08-15
NCT00781300 Intraocular Pressure With Loteprednol and Dexamethasone https://ClinicalTrials.gov/show/NCT00781300 Completed Federal University of São Paulo 2006-11-30
NCT00763061 Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00763061 Completed Alcon Research 2008-04-30
NCT00761709 Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00761709 Completed Alcon Research 2009-10-31
NCT00761319 Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health https://ClinicalTrials.gov/show/NCT00761319 Completed Alcon Research 2009-09-30
NCT00760539 Safety and Efficacy of Travoprost/Timolol BAC-free https://ClinicalTrials.gov/show/NCT00760539 Completed Alcon Research 2008-12-31
NCT00759239 Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00759239 Completed Alcon Research 2011-01-31
NCT00753168 Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT00753168 Completed Othera Pharmaceuticals 2008-12-31
NCT00751127 A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00751127 Completed Pfizer 1994-02-28
NCT00751062 A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia https://ClinicalTrials.gov/show/NCT00751062 Completed Pfizer 1993-12-31
NCT00751049 A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom https://ClinicalTrials.gov/show/NCT00751049 Completed Pfizer 1993-12-31
NCT00721968 Safety and Efficacy of the GTS400 Stent in Conjunction With Cataract https://ClinicalTrials.gov/show/NCT00721968 Completed Glaukos Corporation 2012-02-29
NCT00709449 An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects https://ClinicalTrials.gov/show/NCT00709449 Completed Medical University of Vienna 2009-03-31
NCT00706927 Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00706927 Completed Medical University of Vienna 2010-08-31
NCT00698945 Comparison of Istalolâ„¢ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG) https://ClinicalTrials.gov/show/NCT00698945 Completed Bp Consulting, Inc 2008-11-30
NCT00693485 Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy https://ClinicalTrials.gov/show/NCT00693485 Completed Allergan 2011-01-31
NCT00691717 Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00691717 Completed Alcon Research 2009-09-30
NCT00690794 Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00690794 Completed Alcon Research 2009-05-31
NCT00675207 Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs https://ClinicalTrials.gov/show/NCT00675207 Completed Northwestern Ophthalmic Institute S.C. 2007-07-31
NCT00672997 A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00672997 Completed Alcon Research 2008-12-31
NCT00670033 Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00670033 Completed Alcon Research 2008-09-30
NCT00657579 Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00657579 Completed Santen Pharmaceutical Co., Ltd. NA
NCT00656240 To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00656240 Completed Santen Pharmaceutical Co., Ltd. NA
NCT00650702 Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00650702 Completed Mati Therapeutics Inc. 2009-02-28
NCT00650338 Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00650338 Completed Santen Inc. 2008-09-30
NCT00821002 A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS) https://ClinicalTrials.gov/show/NCT00821002 Completed Mati Therapeutics Inc. 2009-11-30
NCT00647101 A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT00647101 Completed Pfizer NA
NCT00643669 24 Hour IOP Lowering Efficacy of AL-3789 https://ClinicalTrials.gov/show/NCT00643669 Completed Alcon Research 2008-04-30
NCT00637130 Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost https://ClinicalTrials.gov/show/NCT00637130 Completed Alcon Research 2008-01-31
NCT00620256 Adjunctive Study of AL-37807 Ophthalmic Suspension https://ClinicalTrials.gov/show/NCT00620256 Completed Alcon Research 2008-07-31
NCT00596791 Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops https://ClinicalTrials.gov/show/NCT00596791 Completed Santen Oy 2008-07-31
NCT00595101 A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension. https://ClinicalTrials.gov/show/NCT00595101 Completed Bausch & Lomb Incorporated 2008-06-30
NCT00572455 Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure. https://ClinicalTrials.gov/show/NCT00572455 Completed Pfizer 2009-06-30
NCT00570726 Treatment of Failing Blebs With Ranibizumab https://ClinicalTrials.gov/show/NCT00570726 Completed The New York Eye & Ear Infirmary 2007-11-30
NCT00545064 Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED) https://ClinicalTrials.gov/show/NCT00545064 Completed Merck Sharp & Dohme Corp. 2008-09-15
NCT00539526 Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues https://ClinicalTrials.gov/show/NCT00539526 Completed Allergan 2008-07-31
NCT00538590 Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery https://ClinicalTrials.gov/show/NCT00538590 Completed Pro Top & Mediking Company Limited 2010-08-31
NCT00527592 A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00527592 Completed Alcon Research 2008-08-31
NCT00527501 IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00527501 Completed Alcon Research 2007-12-31
NCT00524758 Oculusgen (Ologen) Glaucoma MMC Control in Estonia https://ClinicalTrials.gov/show/NCT00524758 Completed Pro Top & Mediking Company Limited 2011-10-31
NCT00515424 Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension https://ClinicalTrials.gov/show/NCT00515424 Completed Novartis NA
NCT00508469 Adherence Assessment With Travalert Dosing Aid https://ClinicalTrials.gov/show/NCT00508469 Completed Alcon Research 2010-01-31
NCT00485108 Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty https://ClinicalTrials.gov/show/NCT00485108 Completed Queen’s University 2009-06-30
NCT00470964 Titanium-Sapphire Laser Trabeculoplasty in Glaucoma: A Randomized Study Comparing Titanium-Sapphire With Argon Laser Trabeculoplasty in Open-Angle Glaucoma Patients https://ClinicalTrials.gov/show/NCT00470964 Completed Goldschleger Eye Institute NA
NCT00465803 A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00465803 Completed Alcon Research 2009-01-31
NCT00465621 Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00465621 Completed Alcon Research 2007-07-31
NCT00457795 24-hour IOP-lowering Effect of Brimonidine 0.1% https://ClinicalTrials.gov/show/NCT00457795 Completed Allergan 2009-02-28
NCT00451152 Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT00451152 Completed Alcon Research 2009-07-31
NCT00444080 Comparison of Ex-PRESSTM Mini Glaucoma Shunt to Trabeculectomy in Subjects With Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT00444080 Completed University of Virginia 2012-01-31
NCT00443924 Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma https://ClinicalTrials.gov/show/NCT00443924 Completed Merck Sharp & Dohme Corp. 2009-04-30
NCT00441883 Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma https://ClinicalTrials.gov/show/NCT00441883 Completed Bausch & Lomb Incorporated 2008-02-29
NCT00397241 24-hour Intraocular Pressure (IOP) Control With Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combination in Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT00397241 Completed Aristotle University Of Thessaloniki 2007-12-31
NCT00383019 A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH). https://ClinicalTrials.gov/show/NCT00383019 Completed Pfizer 2007-10-31
NCT00372931 A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00372931 Completed Alcon Research 2007-08-31
NCT00372827 Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00372827 Completed Alcon Research 2006-01-31
NCT00314171 A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00314171 Completed Alcon Research 2007-08-31
NCT00331240 24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination https://ClinicalTrials.gov/show/NCT00331240 Completed Aristotle University Of Thessaloniki 2007-01-31
NCT00330577 24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients https://ClinicalTrials.gov/show/NCT00330577 Completed Aristotle University Of Thessaloniki 2007-04-30
NCT00326092 A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00326092 Completed Alcon Research 2006-08-31
NCT00326066 A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients. https://ClinicalTrials.gov/show/NCT00326066 Completed Glaukos Corporation 2013-05-31
NCT00326040 A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects https://ClinicalTrials.gov/show/NCT00326040 Completed Glaukos Corporation NA
NCT00326014 A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects. https://ClinicalTrials.gov/show/NCT00326014 Completed Glaukos Corporation 2008-03-31
NCT00323284 A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT00323284 Completed Glaukos Corporation 2009-07-31
NCT00320203 Anecortave Acetate in Patients With Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT00320203 Completed Alcon Research 2008-01-31
NCT00317577 Study of Medical Treatment of Low-Pressure (Normal Tension) Glaucoma https://ClinicalTrials.gov/show/NCT00317577 Completed Chicago Center for Vision Research NA
NCT00314158 A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00314158 Completed Alcon Research 2007-01-31
NCT00312403 Polymorphisms in the Human Matrix Metalloproteinase Genes MMP1, MMP3, and MMP9: Genetic Risk Factors of Primary Open Angle Glaucoma? https://ClinicalTrials.gov/show/NCT00312403 Completed Medical University of Vienna 2009-11-30
NCT00311389 A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00311389 Completed Alcon Research 2004-09-30
NCT00308945 Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients https://ClinicalTrials.gov/show/NCT00308945 Completed University Hospital, Basel, Switzerland 2005-02-28
NCT00304785 Latanoprost Versus Fotil https://ClinicalTrials.gov/show/NCT00304785 Completed Pharmaceutical Research Network NA
NCT00300079 Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00300079 Completed Alcon Research 2007-09-30
NCT00293800 A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00293800 Completed Alcon Research 2005-12-31
NCT00293787 A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00293787 Completed Alcon Research 2005-08-31
NCT00293761 A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00293761 Completed Alcon Research 2006-05-31
NCT00288951 Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients https://ClinicalTrials.gov/show/NCT00288951 Completed Alcon Research 2005-06-30
NCT00287521 A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00287521 Completed Alcon Research 2006-02-28
NCT00280345 Autoimmune Dysregulation in Pigmentary Glaucoma https://ClinicalTrials.gov/show/NCT00280345 Completed University of Oklahoma 2007-09-30
NCT00277498 A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma https://ClinicalTrials.gov/show/NCT00277498 Completed Pfizer NA
NCT00273481 Cosopt Versus Xalacom https://ClinicalTrials.gov/show/NCT00273481 Completed Pharmaceutical Research Network NA
NCT00273455 Lumigan Versus Cosopt https://ClinicalTrials.gov/show/NCT00273455 Completed Pharmaceutical Research Network NA
NCT00273442 Assessing Cosopt Switch Patients https://ClinicalTrials.gov/show/NCT00273442 Completed Pharmaceutical Research Network NA
NCT00273429 Cosopt Versus Xalatan https://ClinicalTrials.gov/show/NCT00273429 Completed Pharmaceutical Research Network NA
NCT00230763 Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure https://ClinicalTrials.gov/show/NCT00230763 Completed Pfizer 2007-10-31
NCT00219596 Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00219596 Completed Pfizer NA
NCT00798759 Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN https://ClinicalTrials.gov/show/NCT00798759 Completed Alcon Research 2009-05-31
NCT00168350 Memantine in Patients With Chronic Glaucoma https://ClinicalTrials.gov/show/NCT00168350 Completed Allergan 2006-09-30
NCT00159653 A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma https://ClinicalTrials.gov/show/NCT00159653 Completed Pfizer 2007-06-30
NCT00150267 A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00150267 Completed Pfizer NA
NCT00145535 SOLX Titanium Sapphire Laser for Trabeculoplasty https://ClinicalTrials.gov/show/NCT00145535 Completed SOLX, Inc. 2009-06-30
NCT00141882 Memantine in Patients With Chronic Glaucoma https://ClinicalTrials.gov/show/NCT00141882 Completed Allergan 2006-01-31
NCT00140062 Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension. https://ClinicalTrials.gov/show/NCT00140062 Completed Pfizer NA
NCT00140049 A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma https://ClinicalTrials.gov/show/NCT00140049 Completed Pfizer NA
NCT00121147 Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan https://ClinicalTrials.gov/show/NCT00121147 Completed Hermann Eye Center NA
NCT00069719 Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients https://ClinicalTrials.gov/show/NCT00069719 Completed Alcon Research 2003-08-31
NCT00069706 Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients https://ClinicalTrials.gov/show/NCT00069706 Completed Alcon Research 2003-10-31
NCT00061529 A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00061529 Completed Alcon Research 2004-07-31
NCT00051168 A Long-term Safety Study of Once-daily Travatan https://ClinicalTrials.gov/show/NCT00051168 Completed Alcon Research 2009-03-31
NCT00051155 A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT) https://ClinicalTrials.gov/show/NCT00051155 Completed Alcon Research 2004-07-31
NCT00051142 A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) https://ClinicalTrials.gov/show/NCT00051142 Completed Alcon Research 2004-06-30
NCT00047541 Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70 https://ClinicalTrials.gov/show/NCT00047541 Completed Alcon Research 2003-11-30
NCT00047528 Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41 https://ClinicalTrials.gov/show/NCT00047528 Completed Alcon Research 2003-11-30
NCT00047515 Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69 https://ClinicalTrials.gov/show/NCT00047515 Completed Alcon Research 2003-12-31
NCT00047593 Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98 https://ClinicalTrials.gov/show/NCT00047593 Completed Alcon Research 2004-07-31
NCT00051194 A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT00051194 Completed Alcon Research 2003-07-31
NCT00000144 Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS) https://ClinicalTrials.gov/show/NCT00000144 Completed National Eye Institute (NEI) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04461249 Comparison Between Latanoprost , Travoprost and Tafluprost in Reducing IOP Fluctuation in POAG Patients https://ClinicalTrials.gov/show/NCT04461249 Completed Kasr El Aini Hospital 2020-02-28
NCT04141865 Effect of Xen Implantation on the Aqueous Humor Proteome https://ClinicalTrials.gov/show/NCT04141865 Recruiting Price Vision Group 2021-06-30
NCT03373942 The Effect of Pseudoexfoliation on Choroidal Thickness in Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT03373942 Completed Izmir Ataturk Training and Research Hospital 2015-02-15
NCT03325751 Visual Field Defect Estimation Using Sequentially Optimized Reconstruction Strategy on Healthy and Glaucoma Subjects https://ClinicalTrials.gov/show/NCT03325751 Completed University Hospital Inselspital, Berne 2019-08-02
NCT03267862 Scleral Response to Intraocular Pressure (IOP) https://ClinicalTrials.gov/show/NCT03267862 Completed Johns Hopkins University 2017-08-29
NCT03145129 PAIR Study-PAP And IOP Relationship: Study 2 https://ClinicalTrials.gov/show/NCT03145129 Completed Papworth Hospital NHS Foundation Trust 2018-02-10
NCT03021629 Comparison of Vitamin D Status and Vitamin D Receptor Polymorphisms in Patients With High Myopia and Primary Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT03021629 Completed Tianjin Medical University Eye Hospital 2016-12-31
NCT02825264 STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program https://ClinicalTrials.gov/show/NCT02825264 Active, not recruiting iSTAR Medical 2025-12-31
NCT02805231 Associations of Vitamin D Receptor ApaI and Tru9I Polymorphisms With the Risk of Primary Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT02805231 Completed Tianjin Medical University Eye Hospital 2014-12-31
NCT02713152 Prevalence of Obstructive Sleep Apnoea in Glaucoma https://ClinicalTrials.gov/show/NCT02713152 Completed Papworth Hospital NHS Foundation Trust 2017-09-14
NCT02028572 Structure Function Correlation in Primary Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT02028572 Completed Vasan Eye Care Hospital 2014-05-31
NCT02539745 Associations of Vitamin D Deficiency and Vitamin D Receptor Polymorphisms With the Risk of Primary Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT02539745 Completed Tianjin Medical University Eye Hospital 2014-12-31
NCT02348476 A Study of Simbrinzaâ„¢ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT02348476 Completed Allergan 2015-04-30
NCT02228577 Safety and Performance Study of the CyPass System Applier Model 241 https://ClinicalTrials.gov/show/NCT02228577 Completed Alcon Research 2014-10-31
NCT02165631 The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure https://ClinicalTrials.gov/show/NCT02165631 Completed University of Colorado, Denver 2016-03-31
NCT01304264 Intraocular Pressure, Blood Pressure, Ocular Perfusion and Blood Flow Fluctuations in Glaucoma Patients https://ClinicalTrials.gov/show/NCT01304264 Completed Lithuanian University of Health Sciences 2011-09-30
NCT01281020 Adherence With Fixed Versus Unfixed Glaucoma Therapy https://ClinicalTrials.gov/show/NCT01281020 Completed Aristotle University Of Thessaloniki 2011-06-30
NCT01999348 A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting https://ClinicalTrials.gov/show/NCT01999348 Completed Allergan 2014-12-19
NCT01987752 Safety and Efficacy of Combigan® Ophthalmic Solution in Korea https://ClinicalTrials.gov/show/NCT01987752 Completed Allergan 2011-11-30
NCT01976624 Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea https://ClinicalTrials.gov/show/NCT01976624 Completed Allergan 2014-01-31
NCT01923714 Impact of a Tolerability Switch to Dorzolamide/Timolol Preservative-free Fixed Combination on Ocular Surface Symptoms https://ClinicalTrials.gov/show/NCT01923714 Completed Universitaire Ziekenhuizen Leuven 2012-10-31
NCT01895686 Comparison of Gonioscopy With Cirrus and Visante https://ClinicalTrials.gov/show/NCT01895686 Completed Wills Eye 2012-05-31
NCT01857440 The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study https://ClinicalTrials.gov/show/NCT01857440 Completed Ohio State University 2014-12-31
NCT01853085 A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons https://ClinicalTrials.gov/show/NCT01853085 Completed Allergan 2014-03-01
NCT01840215 Study on the Impact of Ocular Anesthetic Procedures in Ocular Blood Flow https://ClinicalTrials.gov/show/NCT01840215 Completed Universitaire Ziekenhuizen Leuven 2014-12-31
NCT01840202 Ocular Blood Flow in Glaucoma Patients - the Leuven Eye Study https://ClinicalTrials.gov/show/NCT01840202 Completed Universitaire Ziekenhuizen Leuven 2014-12-31
NCT01836042 Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort https://ClinicalTrials.gov/show/NCT01836042 Completed Glaukos Corporation 2014-04-30
NCT01814761 A Study of Bimatoprost 0.01% in the Clinical Setting https://ClinicalTrials.gov/show/NCT01814761 Completed Allergan 2014-08-31
NCT01802463 Study on Ocular Blood Flow and the Orbital Cerebrospinal Fluid Pressure in Glaucoma https://ClinicalTrials.gov/show/NCT01802463 Completed Universitaire Ziekenhuizen Leuven 2014-01-31
NCT01779778 Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion Pressure https://ClinicalTrials.gov/show/NCT01779778 Completed University of Colorado, Denver 2013-04-30
NCT01742819 Advanced Glaucoma Progression Study https://ClinicalTrials.gov/show/NCT01742819 Active, not recruiting University of California, Los Angeles 2020-12-31
NCT01742104 Multicentric Observational Study on Quality of Life in Glaucoma https://ClinicalTrials.gov/show/NCT01742104 Completed Mario Negri Institute for Pharmacological Research 2015-02-28
NCT01737853 Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT) https://ClinicalTrials.gov/show/NCT01737853 Completed Allergan S.A. DE C.V.. 2011-02-28
NCT01735214 An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments https://ClinicalTrials.gov/show/NCT01735214 Completed Allergan 2014-04-10
NCT01646151 A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01646151 Completed Allergan 2013-04-30
NCT01637246 A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy https://ClinicalTrials.gov/show/NCT01637246 Completed Allergan 2011-11-30
NCT01633775 Re-Trabeculectomy Versus Ahmed Glaucoma Valve Implantation in Secondary Surgical Management of Patients With Refractory Glaucoma https://ClinicalTrials.gov/show/NCT01633775 Completed Vanak Eye Surgery Center 2012-01-31
NCT01632423 A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) https://ClinicalTrials.gov/show/NCT01632423 Completed Allergan 2010-11-30
NCT01629407 A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years https://ClinicalTrials.gov/show/NCT01629407 Completed Allergan 2013-05-31
NCT01628614 A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) https://ClinicalTrials.gov/show/NCT01628614 Completed Allergan 2011-07-31
NCT01628601 GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy https://ClinicalTrials.gov/show/NCT01628601 Completed Allergan 2011-06-30
NCT01628588 Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) https://ClinicalTrials.gov/show/NCT01628588 Completed Allergan 2010-12-31
NCT01589510 A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) https://ClinicalTrials.gov/show/NCT01589510 Completed Allergan 2013-02-28
NCT01568008 Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) https://ClinicalTrials.gov/show/NCT01568008 Completed Allergan 2012-09-30
NCT01489670 Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension https://ClinicalTrials.gov/show/NCT01489670 Completed Allergan 2013-03-31
NCT01487655 Waveform Analysis of the Doppler Curve of Ophthalmic Arteries in Glaucoma Patients https://ClinicalTrials.gov/show/NCT01487655 Completed Universitaire Ziekenhuizen Leuven 2011-12-31
NCT01484392 Determinants of Compliance With Glaucoma Therapy https://ClinicalTrials.gov/show/NCT01484392 Completed Legacy Health System 2013-12-31
NCT01442896 STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk https://ClinicalTrials.gov/show/NCT01442896 Completed University of California, San Diego 2015-01-27
NCT01391247 Validation of Retinal Oximetry in Glaucoma Patients: a Structural and Functional Correlation https://ClinicalTrials.gov/show/NCT01391247 Completed Universitaire Ziekenhuizen Leuven 2011-12-31
NCT01342406 Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics https://ClinicalTrials.gov/show/NCT01342406 Completed University of Nebraska 2013-11-30
NCT04427995 Standalone OMNI Surgical System for Open-angle Glaucoma https://ClinicalTrials.gov/show/NCT04427995 Recruiting Prism Eye Institute 2020-10-31
NCT04406467 Retrospective Review of Xen Gel Stent Implantation With Open vs. Closed Conjunctiva Approach https://ClinicalTrials.gov/show/NCT04406467 Active, not recruiting Johns Hopkins University 2020-08-31
NCT04396002 Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults https://ClinicalTrials.gov/show/NCT04396002 Recruiting University of Alabama at Birmingham 2021-05-30
NCT04333433 PRESERFLO® MicroShunt Extension Study https://ClinicalTrials.gov/show/NCT04333433 Enrolling by invitation InnFocus Inc. 2023-01-31
NCT04297930 Treatment Outcomes of a Novel Glaucoma Tube Shunt Implant for Intraocular Pressure Control in Eyes With Refractory Glaucoma https://ClinicalTrials.gov/show/NCT04297930 Completed National University Hospital, Singapore 2019-12-01
NCT02863224 Advanced Glycation End Products as a Biomarker for Accelerated Ageing https://ClinicalTrials.gov/show/NCT02863224 Completed University of Plymouth 2018-07-31
NCT04036214 Efficacy and Safety Outcomes of Optometrist Performed Selective Laser Trabeculoplasty (SLT) https://ClinicalTrials.gov/show/NCT04036214 Recruiting Northeastern State University 2020-07-31
NCT04014933 Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System https://ClinicalTrials.gov/show/NCT04014933 Recruiting University of Zurich 2021-02-09
NCT03889652 Optical Coherence Tomography of Nerve Fiber Layer and Ganglion Cell Complex After Cataract Extraction https://ClinicalTrials.gov/show/NCT03889652 Completed Kasr El Aini Hospital 2019-01-30
NCT03695224 Matching Glaucoma With Impaired Cognition https://ClinicalTrials.gov/show/NCT03695224 Recruiting Sun Yat-sen University 2024-09-30
NCT03673644 Impact of Glaucoma and Visual Field Loss on Life Space https://ClinicalTrials.gov/show/NCT03673644 Active, not recruiting University of Alabama at Birmingham 2019-05-30
NCT03445806 IOP Monitoring After Trabeculectomy Using iCare Home https://ClinicalTrials.gov/show/NCT03445806 Recruiting St. Erik Eye Hospital 2019-03-31
NCT01254058 Saccadic Eye Movements Are Impaired In Glaucoma https://ClinicalTrials.gov/show/NCT01254058 Enrolling by invitation St. Michael’s Hospital, Toronto 2020-04-30
NCT01217853 24h Continuous Intraocular Pressure (IOP) Monitoring vs Goldmann Applanation Tonometry https://ClinicalTrials.gov/show/NCT01217853 Completed Sensimed AG 2011-06-30
NCT01097174 CyPass Clinical Experience Study https://ClinicalTrials.gov/show/NCT01097174 Completed Alcon Research 2015-07-31
NCT00981422 Search for Biomarkers in Human Glaucoma: Lymphocytes Alterations and Rate of Progression https://ClinicalTrials.gov/show/NCT00981422 Completed University of Parma 2007-12-31
NCT00823043 A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs https://ClinicalTrials.gov/show/NCT00823043 Completed Vistakon Pharmaceuticals 2009-07-31
NCT01540370 Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT) https://ClinicalTrials.gov/show/NCT01540370 Completed Allergan 2012-07-31
NCT00803504 Correlation of Optic Disk Morphology and Ocular Perfusion Parameters in Patients With Primary Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT00803504 Completed Medical University of Vienna NA
NCT00803387 Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative https://ClinicalTrials.gov/show/NCT00803387 Completed United States Air Force 2008-09-30
NCT00801437 Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy. https://ClinicalTrials.gov/show/NCT00801437 Completed Pfizer 2009-06-30
NCT00716742 Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG) https://ClinicalTrials.gov/show/NCT00716742 Completed Allergan 2007-09-30
NCT00707226 Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes https://ClinicalTrials.gov/show/NCT00707226 Completed Medical University of Vienna NA
NCT00691639 Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP) https://ClinicalTrials.gov/show/NCT00691639 Completed Alcon Research 2009-08-31
NCT00680329 Glaucoma Adherence Study, Spain https://ClinicalTrials.gov/show/NCT00680329 Completed Alcon Research 2009-07-31
NCT00676637 Glaucoma Adherence Study https://ClinicalTrials.gov/show/NCT00676637 Completed Alcon Research 2010-02-28
NCT00626847 How Does Your Genetic Make-up (Profile) Influence Your Glaucoma? https://ClinicalTrials.gov/show/NCT00626847 Completed Wills Eye 2009-08-31
NCT00621335 A Investigator Masked Parallel Comparison of Tolerability of Combigan and Cosopt https://ClinicalTrials.gov/show/NCT00621335 Completed DBYAN Medicine Professional Corporation 2008-02-29
NCT00494923 Early Diagnosis, Pathogenesis and Progression of Open Angle Glaucoma https://ClinicalTrials.gov/show/NCT00494923 Recruiting University of Erlangen-Nürnberg Medical School 2015-12-31
NCT00487214 Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma https://ClinicalTrials.gov/show/NCT00487214 Completed Allergan 2003-02-28
NCT00486252 Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN® https://ClinicalTrials.gov/show/NCT00486252 Completed Pfizer 2008-01-31
NCT00481208 Diurnal Intraocular Pressure and Peripapillary Retinal Blood Flow in Medically Controlled Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT00481208 Completed Yonsei University NA
NCT00430287 Does the Optic Disc Grading Done Visually by Your Doctor Agree With Optic Nerve Testing Which is Done by Machines? https://ClinicalTrials.gov/show/NCT00430287 Completed Wills Eye 2008-10-31
NCT00362622 Determinants of Compliance With Glaucoma Therapy https://ClinicalTrials.gov/show/NCT00362622 Completed University of Alabama at Birmingham NA
NCT00347191 Relationship Between Central Corneal Thickness and Intraocular Pressure Measures Instruments. https://ClinicalTrials.gov/show/NCT00347191 Completed Aston University NA
NCT00334750 Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada https://ClinicalTrials.gov/show/NCT00334750 Completed Pfizer 2009-04-30
NCT00327405 Results of Ocular Compression and Suture Release in Trabeculectomy and Combined Surgery https://ClinicalTrials.gov/show/NCT00327405 Completed University of Cincinnati NA
NCT00221923 African Descent and Glaucoma Evaluation Study https://ClinicalTrials.gov/show/NCT00221923 Enrolling by invitation University of California, San Diego 2020-01-31
NCT00221897 Diagnostic Innovations in Glaucoma Study https://ClinicalTrials.gov/show/NCT00221897 Recruiting University of California, San Diego 2020-07-31
NCT00001152 Pigment Dispersion Syndrome With and Without Glaucoma https://ClinicalTrials.gov/show/NCT00001152 Completed National Institutes of Health Clinical Center (CC) NA
NCT00005919 Cause of Pigment Dispersion Syndrome https://ClinicalTrials.gov/show/NCT00005919 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001161 Abnormalities of the Eye’s Anterior Chamber, Iris, Cornea and Lens https://ClinicalTrials.gov/show/NCT00001161 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT01841437 Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry https://ClinicalTrials.gov/show/NCT01841437 Completed Glaukos Corporation 2016-02-16
NCT01645319 Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma https://ClinicalTrials.gov/show/NCT01645319 Completed Agency for Healthcare Research and Quality (AHRQ) 2013-07-31
NCT04381611 INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register https://ClinicalTrials.gov/show/NCT04381611 Recruiting Swiss Vision Network 2030-01-15